nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA1—esophageal cancer	0.433	0.569	CbGaD
Brinzolamide—CA2—esophageal cancer	0.328	0.431	CbGaD
Brinzolamide—Corneal disorder—Capecitabine—esophageal cancer	0.00402	0.0558	CcSEcCtD
Brinzolamide—CA6—exocrine gland—esophageal cancer	0.00399	0.177	CbGeAlD
Brinzolamide—Dorzolamide—CA1—esophageal cancer	0.00389	0.569	CrCbGaD
Brinzolamide—Dorzolamide—CA2—esophageal cancer	0.00295	0.431	CrCbGaD
Brinzolamide—Keratoconjunctivitis—Capecitabine—esophageal cancer	0.00254	0.0352	CcSEcCtD
Brinzolamide—Motor dysfunction—Methotrexate—esophageal cancer	0.00238	0.033	CcSEcCtD
Brinzolamide—Punctate keratitis—Capecitabine—esophageal cancer	0.00184	0.0255	CcSEcCtD
Brinzolamide—Hypoaesthesia oral—Capecitabine—esophageal cancer	0.00178	0.0247	CcSEcCtD
Brinzolamide—CA7—trachea—esophageal cancer	0.00158	0.0703	CbGeAlD
Brinzolamide—Ocular discomfort—Methotrexate—esophageal cancer	0.00152	0.0211	CcSEcCtD
Brinzolamide—Scab—Capecitabine—esophageal cancer	0.00146	0.0202	CcSEcCtD
Brinzolamide—CA2—exocrine gland—esophageal cancer	0.00137	0.0609	CbGeAlD
Brinzolamide—CA7—digestive system—esophageal cancer	0.00136	0.0605	CbGeAlD
Brinzolamide—Bronchial hyperreactivity—Methotrexate—esophageal cancer	0.00132	0.0184	CcSEcCtD
Brinzolamide—Chronic obstructive pulmonary disease—Methotrexate—esophageal cancer	0.00121	0.0168	CcSEcCtD
Brinzolamide—CA9—digestive system—esophageal cancer	0.0012	0.0531	CbGeAlD
Brinzolamide—CA4—neck—esophageal cancer	0.00106	0.047	CbGeAlD
Brinzolamide—Depressed mood—Capecitabine—esophageal cancer	0.00104	0.0144	CcSEcCtD
Brinzolamide—CA12—trachea—esophageal cancer	0.00103	0.0457	CbGeAlD
Brinzolamide—Paraesthesia oral—Capecitabine—esophageal cancer	0.000989	0.0137	CcSEcCtD
Brinzolamide—CA12—digestive system—esophageal cancer	0.000886	0.0393	CbGeAlD
Brinzolamide—CA2—neck—esophageal cancer	0.000879	0.039	CbGeAlD
Brinzolamide—Sneezing—Capecitabine—esophageal cancer	0.000838	0.0116	CcSEcCtD
Brinzolamide—Visual acuity reduced—Capecitabine—esophageal cancer	0.00078	0.0108	CcSEcCtD
Brinzolamide—Ageusia—Cisplatin—esophageal cancer	0.000776	0.0108	CcSEcCtD
Brinzolamide—Rhinorrhoea—Cisplatin—esophageal cancer	0.000776	0.0108	CcSEcCtD
Brinzolamide—Infection—Carboplatin—esophageal cancer	0.00076	0.0105	CcSEcCtD
Brinzolamide—CA12—lung—esophageal cancer	0.00074	0.0328	CbGeAlD
Brinzolamide—Keratitis—Capecitabine—esophageal cancer	0.000715	0.00992	CcSEcCtD
Brinzolamide—CA1—digestive system—esophageal cancer	0.000702	0.0311	CbGeAlD
Brinzolamide—Pharyngolaryngeal pain—Capecitabine—esophageal cancer	0.000687	0.00953	CcSEcCtD
Brinzolamide—Laryngeal pain—Capecitabine—esophageal cancer	0.00068	0.00944	CcSEcCtD
Brinzolamide—CA5B—lung—esophageal cancer	0.000664	0.0294	CbGeAlD
Brinzolamide—Pain—Carboplatin—esophageal cancer	0.000654	0.00908	CcSEcCtD
Brinzolamide—CA4—trachea—esophageal cancer	0.000638	0.0283	CbGeAlD
Brinzolamide—CA2—epithelium—esophageal cancer	0.000598	0.0265	CbGeAlD
Brinzolamide—Memory impairment—Capecitabine—esophageal cancer	0.000591	0.0082	CcSEcCtD
Brinzolamide—CA2—bronchus—esophageal cancer	0.000589	0.0261	CbGeAlD
Brinzolamide—CA1—lung—esophageal cancer	0.000586	0.026	CbGeAlD
Brinzolamide—CA2—smooth muscle tissue—esophageal cancer	0.000576	0.0255	CbGeAlD
Brinzolamide—Rhinorrhoea—Capecitabine—esophageal cancer	0.000572	0.00794	CcSEcCtD
Brinzolamide—Ageusia—Capecitabine—esophageal cancer	0.000572	0.00794	CcSEcCtD
Brinzolamide—CA4—digestive system—esophageal cancer	0.000548	0.0243	CbGeAlD
Brinzolamide—Eye irritation—Capecitabine—esophageal cancer	0.000543	0.00754	CcSEcCtD
Brinzolamide—CA2—trachea—esophageal cancer	0.000529	0.0234	CbGeAlD
Brinzolamide—Chest discomfort—Capecitabine—esophageal cancer	0.000524	0.00727	CcSEcCtD
Brinzolamide—Oropharyngeal pain—Capecitabine—esophageal cancer	0.00051	0.00708	CcSEcCtD
Brinzolamide—Lacrimation increased—Capecitabine—esophageal cancer	0.000503	0.00698	CcSEcCtD
Brinzolamide—Nasal congestion—Cisplatin—esophageal cancer	0.000501	0.00696	CcSEcCtD
Brinzolamide—Amnesia—Cisplatin—esophageal cancer	0.000486	0.00674	CcSEcCtD
Brinzolamide—Blood pressure increased—Capecitabine—esophageal cancer	0.000464	0.00644	CcSEcCtD
Brinzolamide—CA4—lung—esophageal cancer	0.000458	0.0203	CbGeAlD
Brinzolamide—CA2—digestive system—esophageal cancer	0.000455	0.0202	CbGeAlD
Brinzolamide—CA5B—lymph node—esophageal cancer	0.000454	0.0201	CbGeAlD
Brinzolamide—Irritability—Cisplatin—esophageal cancer	0.000436	0.00605	CcSEcCtD
Brinzolamide—Dry eye—Capecitabine—esophageal cancer	0.000428	0.00594	CcSEcCtD
Brinzolamide—Oesophagitis—Capecitabine—esophageal cancer	0.000424	0.00588	CcSEcCtD
Brinzolamide—Breast disorder—Cisplatin—esophageal cancer	0.000413	0.00573	CcSEcCtD
Brinzolamide—Nasopharyngitis—Cisplatin—esophageal cancer	0.000408	0.00567	CcSEcCtD
Brinzolamide—Abnormal vision—Capecitabine—esophageal cancer	0.000404	0.00561	CcSEcCtD
Brinzolamide—CA1—lymph node—esophageal cancer	0.000401	0.0178	CbGeAlD
Brinzolamide—CA2—lung—esophageal cancer	0.00038	0.0168	CbGeAlD
Brinzolamide—Abdominal discomfort—Cisplatin—esophageal cancer	0.000378	0.00525	CcSEcCtD
Brinzolamide—Eye pain—Capecitabine—esophageal cancer	0.000373	0.00517	CcSEcCtD
Brinzolamide—Libido decreased—Capecitabine—esophageal cancer	0.000363	0.00504	CcSEcCtD
Brinzolamide—Amnesia—Capecitabine—esophageal cancer	0.000358	0.00497	CcSEcCtD
Brinzolamide—Conjunctivitis—Cisplatin—esophageal cancer	0.000342	0.00475	CcSEcCtD
Brinzolamide—Pain in extremity—Capecitabine—esophageal cancer	0.000337	0.00467	CcSEcCtD
Brinzolamide—Diplopia—Capecitabine—esophageal cancer	0.000337	0.00467	CcSEcCtD
Brinzolamide—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000334	0.00463	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000333	0.00462	CcSEcCtD
Brinzolamide—Bradycardia—Cisplatin—esophageal cancer	0.000322	0.00446	CcSEcCtD
Brinzolamide—Irritability—Capecitabine—esophageal cancer	0.000321	0.00446	CcSEcCtD
Brinzolamide—CA4—lymph node—esophageal cancer	0.000313	0.0139	CbGeAlD
Brinzolamide—Urinary tract disorder—Cisplatin—esophageal cancer	0.000312	0.00433	CcSEcCtD
Brinzolamide—Liver function test abnormal—Capecitabine—esophageal cancer	0.000311	0.00431	CcSEcCtD
Brinzolamide—Connective tissue disorder—Cisplatin—esophageal cancer	0.00031	0.00431	CcSEcCtD
Brinzolamide—Urethral disorder—Cisplatin—esophageal cancer	0.00031	0.0043	CcSEcCtD
Brinzolamide—Abdominal pain upper—Capecitabine—esophageal cancer	0.000307	0.00427	CcSEcCtD
Brinzolamide—Visual impairment—Cisplatin—esophageal cancer	0.000304	0.00422	CcSEcCtD
Brinzolamide—Breast disorder—Capecitabine—esophageal cancer	0.000304	0.00422	CcSEcCtD
Brinzolamide—Nasopharyngitis—Capecitabine—esophageal cancer	0.000301	0.00418	CcSEcCtD
Brinzolamide—Eye disorder—Cisplatin—esophageal cancer	0.000295	0.0041	CcSEcCtD
Brinzolamide—Tinnitus—Cisplatin—esophageal cancer	0.000295	0.00409	CcSEcCtD
Brinzolamide—CYP3A4—digestive system—esophageal cancer	0.000293	0.013	CbGeAlD
Brinzolamide—Cardiac disorder—Cisplatin—esophageal cancer	0.000293	0.00407	CcSEcCtD
Brinzolamide—Asthma—Capecitabine—esophageal cancer	0.000291	0.00404	CcSEcCtD
Brinzolamide—Immune system disorder—Cisplatin—esophageal cancer	0.000285	0.00396	CcSEcCtD
Brinzolamide—Mediastinal disorder—Cisplatin—esophageal cancer	0.000285	0.00395	CcSEcCtD
Brinzolamide—Angina pectoris—Capecitabine—esophageal cancer	0.000283	0.00393	CcSEcCtD
Brinzolamide—Arrhythmia—Cisplatin—esophageal cancer	0.000282	0.00392	CcSEcCtD
Brinzolamide—Bronchitis—Capecitabine—esophageal cancer	0.00028	0.00388	CcSEcCtD
Brinzolamide—Alopecia—Cisplatin—esophageal cancer	0.000279	0.00387	CcSEcCtD
Brinzolamide—Abdominal discomfort—Capecitabine—esophageal cancer	0.000279	0.00387	CcSEcCtD
Brinzolamide—Malnutrition—Cisplatin—esophageal cancer	0.000275	0.00382	CcSEcCtD
Brinzolamide—Erythema—Cisplatin—esophageal cancer	0.000275	0.00382	CcSEcCtD
Brinzolamide—Flatulence—Cisplatin—esophageal cancer	0.000271	0.00376	CcSEcCtD
Brinzolamide—Visual disturbance—Methotrexate—esophageal cancer	0.000264	0.00367	CcSEcCtD
Brinzolamide—Muscle spasms—Cisplatin—esophageal cancer	0.000264	0.00367	CcSEcCtD
Brinzolamide—CA2—lymph node—esophageal cancer	0.00026	0.0115	CbGeAlD
Brinzolamide—Infestation NOS—Capecitabine—esophageal cancer	0.000259	0.0036	CcSEcCtD
Brinzolamide—Infestation—Capecitabine—esophageal cancer	0.000259	0.0036	CcSEcCtD
Brinzolamide—Vision blurred—Cisplatin—esophageal cancer	0.000259	0.0036	CcSEcCtD
Brinzolamide—Depression—Capecitabine—esophageal cancer	0.000259	0.00359	CcSEcCtD
Brinzolamide—Tremor—Cisplatin—esophageal cancer	0.000258	0.00358	CcSEcCtD
Brinzolamide—Ill-defined disorder—Cisplatin—esophageal cancer	0.000255	0.00354	CcSEcCtD
Brinzolamide—Conjunctivitis—Capecitabine—esophageal cancer	0.000252	0.0035	CcSEcCtD
Brinzolamide—Malaise—Cisplatin—esophageal cancer	0.000248	0.00344	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000245	0.0034	CcSEcCtD
Brinzolamide—Epistaxis—Capecitabine—esophageal cancer	0.000245	0.0034	CcSEcCtD
Brinzolamide—Irritability—Methotrexate—esophageal cancer	0.000239	0.00332	CcSEcCtD
Brinzolamide—Bradycardia—Capecitabine—esophageal cancer	0.000237	0.00329	CcSEcCtD
Brinzolamide—Myalgia—Cisplatin—esophageal cancer	0.000234	0.00325	CcSEcCtD
Brinzolamide—Rhinitis—Capecitabine—esophageal cancer	0.000233	0.00324	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000233	0.00323	CcSEcCtD
Brinzolamide—Hypoaesthesia—Capecitabine—esophageal cancer	0.000232	0.00322	CcSEcCtD
Brinzolamide—Liver function test abnormal—Methotrexate—esophageal cancer	0.000231	0.00321	CcSEcCtD
Brinzolamide—Discomfort—Cisplatin—esophageal cancer	0.000231	0.00321	CcSEcCtD
Brinzolamide—Pharyngitis—Capecitabine—esophageal cancer	0.000231	0.00321	CcSEcCtD
Brinzolamide—Urinary tract disorder—Capecitabine—esophageal cancer	0.00023	0.00319	CcSEcCtD
Brinzolamide—Oedema peripheral—Capecitabine—esophageal cancer	0.000229	0.00318	CcSEcCtD
Brinzolamide—Connective tissue disorder—Capecitabine—esophageal cancer	0.000229	0.00318	CcSEcCtD
Brinzolamide—Urethral disorder—Capecitabine—esophageal cancer	0.000228	0.00317	CcSEcCtD
Brinzolamide—Breast disorder—Methotrexate—esophageal cancer	0.000226	0.00314	CcSEcCtD
Brinzolamide—Visual impairment—Capecitabine—esophageal cancer	0.000224	0.00311	CcSEcCtD
Brinzolamide—Infection—Cisplatin—esophageal cancer	0.000223	0.00309	CcSEcCtD
Brinzolamide—Nervous system disorder—Cisplatin—esophageal cancer	0.00022	0.00305	CcSEcCtD
Brinzolamide—Tachycardia—Cisplatin—esophageal cancer	0.000219	0.00304	CcSEcCtD
Brinzolamide—Skin disorder—Cisplatin—esophageal cancer	0.000218	0.00303	CcSEcCtD
Brinzolamide—Eye disorder—Capecitabine—esophageal cancer	0.000218	0.00302	CcSEcCtD
Brinzolamide—Tinnitus—Capecitabine—esophageal cancer	0.000217	0.00301	CcSEcCtD
Brinzolamide—Asthma—Methotrexate—esophageal cancer	0.000217	0.00301	CcSEcCtD
Brinzolamide—Cardiac disorder—Capecitabine—esophageal cancer	0.000216	0.003	CcSEcCtD
Brinzolamide—Angiopathy—Capecitabine—esophageal cancer	0.000211	0.00293	CcSEcCtD
Brinzolamide—Immune system disorder—Capecitabine—esophageal cancer	0.00021	0.00292	CcSEcCtD
Brinzolamide—Mediastinal disorder—Capecitabine—esophageal cancer	0.00021	0.00291	CcSEcCtD
Brinzolamide—Hypotension—Cisplatin—esophageal cancer	0.00021	0.00291	CcSEcCtD
Brinzolamide—Arrhythmia—Capecitabine—esophageal cancer	0.000208	0.00289	CcSEcCtD
Brinzolamide—Abdominal discomfort—Methotrexate—esophageal cancer	0.000208	0.00288	CcSEcCtD
Brinzolamide—Alopecia—Capecitabine—esophageal cancer	0.000206	0.00286	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000204	0.00284	CcSEcCtD
Brinzolamide—Mental disorder—Capecitabine—esophageal cancer	0.000204	0.00283	CcSEcCtD
Brinzolamide—Malnutrition—Capecitabine—esophageal cancer	0.000203	0.00281	CcSEcCtD
Brinzolamide—Erythema—Capecitabine—esophageal cancer	0.000203	0.00281	CcSEcCtD
Brinzolamide—Paraesthesia—Cisplatin—esophageal cancer	0.000202	0.0028	CcSEcCtD
Brinzolamide—Dyspnoea—Cisplatin—esophageal cancer	0.0002	0.00278	CcSEcCtD
Brinzolamide—Flatulence—Capecitabine—esophageal cancer	0.0002	0.00277	CcSEcCtD
Brinzolamide—Erectile dysfunction—Methotrexate—esophageal cancer	0.000199	0.00277	CcSEcCtD
Brinzolamide—Dysgeusia—Capecitabine—esophageal cancer	0.000199	0.00275	CcSEcCtD
Brinzolamide—Back pain—Capecitabine—esophageal cancer	0.000196	0.00272	CcSEcCtD
Brinzolamide—Decreased appetite—Cisplatin—esophageal cancer	0.000195	0.00271	CcSEcCtD
Brinzolamide—Muscle spasms—Capecitabine—esophageal cancer	0.000195	0.0027	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000194	0.00269	CcSEcCtD
Brinzolamide—Infestation NOS—Methotrexate—esophageal cancer	0.000193	0.00268	CcSEcCtD
Brinzolamide—Infestation—Methotrexate—esophageal cancer	0.000193	0.00268	CcSEcCtD
Brinzolamide—Depression—Methotrexate—esophageal cancer	0.000193	0.00267	CcSEcCtD
Brinzolamide—Pain—Cisplatin—esophageal cancer	0.000192	0.00266	CcSEcCtD
Brinzolamide—Vision blurred—Capecitabine—esophageal cancer	0.000191	0.00265	CcSEcCtD
Brinzolamide—Tremor—Capecitabine—esophageal cancer	0.00019	0.00264	CcSEcCtD
Brinzolamide—Ill-defined disorder—Capecitabine—esophageal cancer	0.000188	0.00261	CcSEcCtD
Brinzolamide—Conjunctivitis—Methotrexate—esophageal cancer	0.000188	0.0026	CcSEcCtD
Brinzolamide—Feeling abnormal—Cisplatin—esophageal cancer	0.000185	0.00257	CcSEcCtD
Brinzolamide—Malaise—Capecitabine—esophageal cancer	0.000183	0.00254	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000183	0.00253	CcSEcCtD
Brinzolamide—Epistaxis—Methotrexate—esophageal cancer	0.000182	0.00253	CcSEcCtD
Brinzolamide—Vertigo—Capecitabine—esophageal cancer	0.000182	0.00253	CcSEcCtD
Brinzolamide—Palpitations—Capecitabine—esophageal cancer	0.000179	0.00249	CcSEcCtD
Brinzolamide—Cough—Capecitabine—esophageal cancer	0.000177	0.00245	CcSEcCtD
Brinzolamide—Hypertension—Capecitabine—esophageal cancer	0.000175	0.00243	CcSEcCtD
Brinzolamide—Arthralgia—Capecitabine—esophageal cancer	0.000173	0.00239	CcSEcCtD
Brinzolamide—Chest pain—Capecitabine—esophageal cancer	0.000173	0.00239	CcSEcCtD
Brinzolamide—Myalgia—Capecitabine—esophageal cancer	0.000173	0.00239	CcSEcCtD
Brinzolamide—Pharyngitis—Methotrexate—esophageal cancer	0.000172	0.00239	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000171	0.00238	CcSEcCtD
Brinzolamide—Urinary tract disorder—Methotrexate—esophageal cancer	0.000171	0.00238	CcSEcCtD
Brinzolamide—Discomfort—Capecitabine—esophageal cancer	0.000171	0.00237	CcSEcCtD
Brinzolamide—Urethral disorder—Methotrexate—esophageal cancer	0.00017	0.00236	CcSEcCtD
Brinzolamide—Dry mouth—Capecitabine—esophageal cancer	0.000169	0.00234	CcSEcCtD
Brinzolamide—Visual impairment—Methotrexate—esophageal cancer	0.000167	0.00232	CcSEcCtD
Brinzolamide—Hypersensitivity—Cisplatin—esophageal cancer	0.000165	0.00229	CcSEcCtD
Brinzolamide—Infection—Capecitabine—esophageal cancer	0.000164	0.00228	CcSEcCtD
Brinzolamide—Nervous system disorder—Capecitabine—esophageal cancer	0.000162	0.00225	CcSEcCtD
Brinzolamide—Eye disorder—Methotrexate—esophageal cancer	0.000162	0.00225	CcSEcCtD
Brinzolamide—Tinnitus—Methotrexate—esophageal cancer	0.000162	0.00224	CcSEcCtD
Brinzolamide—Tachycardia—Capecitabine—esophageal cancer	0.000161	0.00224	CcSEcCtD
Brinzolamide—Asthenia—Cisplatin—esophageal cancer	0.000161	0.00223	CcSEcCtD
Brinzolamide—Cardiac disorder—Methotrexate—esophageal cancer	0.000161	0.00223	CcSEcCtD
Brinzolamide—Skin disorder—Capecitabine—esophageal cancer	0.000161	0.00223	CcSEcCtD
Brinzolamide—Angiopathy—Methotrexate—esophageal cancer	0.000157	0.00218	CcSEcCtD
Brinzolamide—Immune system disorder—Methotrexate—esophageal cancer	0.000157	0.00217	CcSEcCtD
Brinzolamide—Mediastinal disorder—Methotrexate—esophageal cancer	0.000156	0.00217	CcSEcCtD
Brinzolamide—Hypotension—Capecitabine—esophageal cancer	0.000155	0.00215	CcSEcCtD
Brinzolamide—Diarrhoea—Cisplatin—esophageal cancer	0.000154	0.00213	CcSEcCtD
Brinzolamide—Alopecia—Methotrexate—esophageal cancer	0.000153	0.00213	CcSEcCtD
Brinzolamide—Mental disorder—Methotrexate—esophageal cancer	0.000152	0.00211	CcSEcCtD
Brinzolamide—Erythema—Methotrexate—esophageal cancer	0.000151	0.00209	CcSEcCtD
Brinzolamide—Malnutrition—Methotrexate—esophageal cancer	0.000151	0.00209	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000151	0.00209	CcSEcCtD
Brinzolamide—Insomnia—Capecitabine—esophageal cancer	0.00015	0.00208	CcSEcCtD
Brinzolamide—Paraesthesia—Capecitabine—esophageal cancer	0.000149	0.00206	CcSEcCtD
Brinzolamide—Dysgeusia—Methotrexate—esophageal cancer	0.000148	0.00205	CcSEcCtD
Brinzolamide—Dyspnoea—Capecitabine—esophageal cancer	0.000147	0.00205	CcSEcCtD
Brinzolamide—Back pain—Methotrexate—esophageal cancer	0.000146	0.00203	CcSEcCtD
Brinzolamide—Dyspepsia—Capecitabine—esophageal cancer	0.000146	0.00202	CcSEcCtD
Brinzolamide—Decreased appetite—Capecitabine—esophageal cancer	0.000144	0.002	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000143	0.00198	CcSEcCtD
Brinzolamide—Vomiting—Cisplatin—esophageal cancer	0.000143	0.00198	CcSEcCtD
Brinzolamide—Fatigue—Capecitabine—esophageal cancer	0.000143	0.00198	CcSEcCtD
Brinzolamide—Vision blurred—Methotrexate—esophageal cancer	0.000142	0.00197	CcSEcCtD
Brinzolamide—Rash—Cisplatin—esophageal cancer	0.000142	0.00196	CcSEcCtD
Brinzolamide—Pain—Capecitabine—esophageal cancer	0.000141	0.00196	CcSEcCtD
Brinzolamide—Dermatitis—Cisplatin—esophageal cancer	0.000141	0.00196	CcSEcCtD
Brinzolamide—Ill-defined disorder—Methotrexate—esophageal cancer	0.00014	0.00194	CcSEcCtD
Brinzolamide—Feeling abnormal—Capecitabine—esophageal cancer	0.000136	0.00189	CcSEcCtD
Brinzolamide—Malaise—Methotrexate—esophageal cancer	0.000136	0.00189	CcSEcCtD
Brinzolamide—Vertigo—Methotrexate—esophageal cancer	0.000136	0.00188	CcSEcCtD
Brinzolamide—Nausea—Cisplatin—esophageal cancer	0.000133	0.00185	CcSEcCtD
Brinzolamide—Cough—Methotrexate—esophageal cancer	0.000132	0.00183	CcSEcCtD
Brinzolamide—Urticaria—Capecitabine—esophageal cancer	0.000131	0.00182	CcSEcCtD
Brinzolamide—Arthralgia—Methotrexate—esophageal cancer	0.000128	0.00178	CcSEcCtD
Brinzolamide—Chest pain—Methotrexate—esophageal cancer	0.000128	0.00178	CcSEcCtD
Brinzolamide—Myalgia—Methotrexate—esophageal cancer	0.000128	0.00178	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000128	0.00177	CcSEcCtD
Brinzolamide—Discomfort—Methotrexate—esophageal cancer	0.000127	0.00176	CcSEcCtD
Brinzolamide—Infection—Methotrexate—esophageal cancer	0.000122	0.0017	CcSEcCtD
Brinzolamide—Hypersensitivity—Capecitabine—esophageal cancer	0.000122	0.00169	CcSEcCtD
Brinzolamide—Nervous system disorder—Methotrexate—esophageal cancer	0.000121	0.00168	CcSEcCtD
Brinzolamide—Skin disorder—Methotrexate—esophageal cancer	0.00012	0.00166	CcSEcCtD
Brinzolamide—Asthenia—Capecitabine—esophageal cancer	0.000119	0.00165	CcSEcCtD
Brinzolamide—Pruritus—Capecitabine—esophageal cancer	0.000117	0.00162	CcSEcCtD
Brinzolamide—Hypotension—Methotrexate—esophageal cancer	0.000115	0.0016	CcSEcCtD
Brinzolamide—Diarrhoea—Capecitabine—esophageal cancer	0.000113	0.00157	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000112	0.00156	CcSEcCtD
Brinzolamide—Insomnia—Methotrexate—esophageal cancer	0.000111	0.00155	CcSEcCtD
Brinzolamide—Paraesthesia—Methotrexate—esophageal cancer	0.000111	0.00153	CcSEcCtD
Brinzolamide—Dyspnoea—Methotrexate—esophageal cancer	0.00011	0.00152	CcSEcCtD
Brinzolamide—Somnolence—Methotrexate—esophageal cancer	0.000109	0.00152	CcSEcCtD
Brinzolamide—Dizziness—Capecitabine—esophageal cancer	0.000109	0.00152	CcSEcCtD
Brinzolamide—Dyspepsia—Methotrexate—esophageal cancer	0.000108	0.0015	CcSEcCtD
Brinzolamide—Decreased appetite—Methotrexate—esophageal cancer	0.000107	0.00149	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000106	0.00148	CcSEcCtD
Brinzolamide—Fatigue—Methotrexate—esophageal cancer	0.000106	0.00147	CcSEcCtD
Brinzolamide—Pain—Methotrexate—esophageal cancer	0.000105	0.00146	CcSEcCtD
Brinzolamide—Vomiting—Capecitabine—esophageal cancer	0.000105	0.00146	CcSEcCtD
Brinzolamide—Rash—Capecitabine—esophageal cancer	0.000104	0.00145	CcSEcCtD
Brinzolamide—Dermatitis—Capecitabine—esophageal cancer	0.000104	0.00145	CcSEcCtD
Brinzolamide—Headache—Capecitabine—esophageal cancer	0.000104	0.00144	CcSEcCtD
Brinzolamide—Feeling abnormal—Methotrexate—esophageal cancer	0.000101	0.00141	CcSEcCtD
Brinzolamide—Nausea—Capecitabine—esophageal cancer	9.83e-05	0.00136	CcSEcCtD
Brinzolamide—Urticaria—Methotrexate—esophageal cancer	9.78e-05	0.00136	CcSEcCtD
Brinzolamide—Hypersensitivity—Methotrexate—esophageal cancer	9.07e-05	0.00126	CcSEcCtD
Brinzolamide—Asthenia—Methotrexate—esophageal cancer	8.84e-05	0.00123	CcSEcCtD
Brinzolamide—Pruritus—Methotrexate—esophageal cancer	8.71e-05	0.00121	CcSEcCtD
Brinzolamide—Diarrhoea—Methotrexate—esophageal cancer	8.43e-05	0.00117	CcSEcCtD
Brinzolamide—Dizziness—Methotrexate—esophageal cancer	8.14e-05	0.00113	CcSEcCtD
Brinzolamide—Vomiting—Methotrexate—esophageal cancer	7.83e-05	0.00109	CcSEcCtD
Brinzolamide—Rash—Methotrexate—esophageal cancer	7.77e-05	0.00108	CcSEcCtD
Brinzolamide—Dermatitis—Methotrexate—esophageal cancer	7.76e-05	0.00108	CcSEcCtD
Brinzolamide—Headache—Methotrexate—esophageal cancer	7.72e-05	0.00107	CcSEcCtD
Brinzolamide—Nausea—Methotrexate—esophageal cancer	7.32e-05	0.00102	CcSEcCtD
Brinzolamide—CA5A—Metabolism—CYP2A6—esophageal cancer	5.83e-05	0.000424	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ADH1B—esophageal cancer	5.82e-05	0.000423	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—TYMP—esophageal cancer	5.8e-05	0.000422	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ALDH2—esophageal cancer	5.78e-05	0.000421	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ALDH2—esophageal cancer	5.78e-05	0.000421	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GNG7—esophageal cancer	5.72e-05	0.000416	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	5.7e-05	0.000415	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS1—esophageal cancer	5.67e-05	0.000413	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ENO1—esophageal cancer	5.67e-05	0.000413	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP26A1—esophageal cancer	5.64e-05	0.000411	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	5.63e-05	0.00041	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PLCE1—esophageal cancer	5.59e-05	0.000407	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ADH7—esophageal cancer	5.59e-05	0.000407	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PSME1—esophageal cancer	5.58e-05	0.000407	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PSME2—esophageal cancer	5.58e-05	0.000407	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ADH1B—esophageal cancer	5.58e-05	0.000406	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—TYMP—esophageal cancer	5.56e-05	0.000405	CbGpPWpGaD
Brinzolamide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	5.55e-05	0.000404	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS1—esophageal cancer	5.52e-05	0.000402	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ENO1—esophageal cancer	5.52e-05	0.000402	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ENO1—esophageal cancer	5.52e-05	0.000402	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS1—esophageal cancer	5.52e-05	0.000402	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—ADH7—esophageal cancer	5.5e-05	0.000401	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GSTT1—esophageal cancer	5.5e-05	0.000401	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GSTT1—esophageal cancer	5.5e-05	0.000401	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALOX15—esophageal cancer	5.5e-05	0.0004	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PSME2—esophageal cancer	5.44e-05	0.000396	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PSME1—esophageal cancer	5.44e-05	0.000396	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PSME2—esophageal cancer	5.44e-05	0.000396	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PSME1—esophageal cancer	5.44e-05	0.000396	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP2A6—esophageal cancer	5.44e-05	0.000396	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP2A6—esophageal cancer	5.44e-05	0.000396	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP26A1—esophageal cancer	5.41e-05	0.000394	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ALDH2—esophageal cancer	5.36e-05	0.00039	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—TYMP—esophageal cancer	5.33e-05	0.000388	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALOX15—esophageal cancer	5.27e-05	0.000384	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTO1—esophageal cancer	5.24e-05	0.000382	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—TPI1—esophageal cancer	5.24e-05	0.000382	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CDKN2A—esophageal cancer	5.24e-05	0.000381	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP26A1—esophageal cancer	5.18e-05	0.000377	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ENO1—esophageal cancer	5.16e-05	0.000375	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ENO1—esophageal cancer	5.16e-05	0.000375	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS1—esophageal cancer	5.16e-05	0.000375	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS1—esophageal cancer	5.16e-05	0.000375	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GSTT1—esophageal cancer	5.1e-05	0.000371	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PSME2—esophageal cancer	5.08e-05	0.00037	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PSME2—esophageal cancer	5.08e-05	0.00037	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PSME1—esophageal cancer	5.08e-05	0.00037	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PSME1—esophageal cancer	5.08e-05	0.00037	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALOX15—esophageal cancer	5.05e-05	0.000368	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP2A6—esophageal cancer	5.04e-05	0.000367	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTO1—esophageal cancer	5.03e-05	0.000366	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—TPI1—esophageal cancer	5.03e-05	0.000366	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALDOB—esophageal cancer	5.03e-05	0.000366	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ADH1B—esophageal cancer	4.9e-05	0.000357	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	4.85e-05	0.000353	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GAPDH—esophageal cancer	4.84e-05	0.000352	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	4.83e-05	0.000351	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP1B1—esophageal cancer	4.82e-05	0.000351	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTO1—esophageal cancer	4.82e-05	0.000351	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—TPI1—esophageal cancer	4.82e-05	0.000351	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALDOB—esophageal cancer	4.82e-05	0.000351	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CRABP1—esophageal cancer	4.8e-05	0.000349	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ENO1—esophageal cancer	4.78e-05	0.000348	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS1—esophageal cancer	4.78e-05	0.000348	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PSME2—esophageal cancer	4.71e-05	0.000343	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PSME1—esophageal cancer	4.71e-05	0.000343	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP1B1—esophageal cancer	4.7e-05	0.000342	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP1B1—esophageal cancer	4.7e-05	0.000342	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—TYMP—esophageal cancer	4.68e-05	0.000341	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GAPDH—esophageal cancer	4.64e-05	0.000338	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALDOB—esophageal cancer	4.62e-05	0.000336	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CRABP1—esophageal cancer	4.6e-05	0.000335	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GNG7—esophageal cancer	4.56e-05	0.000332	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	4.56e-05	0.000332	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP26A1—esophageal cancer	4.56e-05	0.000332	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CYP19A1—esophageal cancer	4.53e-05	0.00033	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	4.49e-05	0.000327	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GAPDH—esophageal cancer	4.45e-05	0.000324	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALOX15—esophageal cancer	4.44e-05	0.000323	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	4.42e-05	0.000322	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CYP19A1—esophageal cancer	4.42e-05	0.000321	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CYP19A1—esophageal cancer	4.42e-05	0.000321	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CRABP1—esophageal cancer	4.41e-05	0.000321	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP1B1—esophageal cancer	4.38e-05	0.000319	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP1B1—esophageal cancer	4.38e-05	0.000319	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GNG7—esophageal cancer	4.37e-05	0.000318	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—CDKN1A—esophageal cancer	4.28e-05	0.000312	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALDH2—esophageal cancer	4.27e-05	0.000311	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—TPI1—esophageal cancer	4.24e-05	0.000308	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTO1—esophageal cancer	4.24e-05	0.000308	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GNG7—esophageal cancer	4.19e-05	0.000305	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	4.17e-05	0.000304	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—HMOX1—esophageal cancer	4.13e-05	0.000301	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP19A1—esophageal cancer	4.12e-05	0.0003	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP19A1—esophageal cancer	4.12e-05	0.0003	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	4.11e-05	0.000299	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALDH2—esophageal cancer	4.1e-05	0.000298	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—EP300—esophageal cancer	4.07e-05	0.000296	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GSTT1—esophageal cancer	4.07e-05	0.000296	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALDOB—esophageal cancer	4.06e-05	0.000296	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP1B1—esophageal cancer	4.06e-05	0.000296	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—HMOX1—esophageal cancer	4.03e-05	0.000293	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—HMOX1—esophageal cancer	4.03e-05	0.000293	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP2A6—esophageal cancer	4.02e-05	0.000293	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ABCB1—esophageal cancer	3.97e-05	0.000289	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALDH2—esophageal cancer	3.93e-05	0.000286	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GAPDH—esophageal cancer	3.91e-05	0.000285	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTT1—esophageal cancer	3.9e-05	0.000284	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CRABP1—esophageal cancer	3.87e-05	0.000282	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ABCB1—esophageal cancer	3.87e-05	0.000282	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ABCB1—esophageal cancer	3.87e-05	0.000282	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP2A6—esophageal cancer	3.85e-05	0.00028	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP19A1—esophageal cancer	3.82e-05	0.000278	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ENO1—esophageal cancer	3.81e-05	0.000277	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS1—esophageal cancer	3.81e-05	0.000277	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—HMOX1—esophageal cancer	3.76e-05	0.000274	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—HMOX1—esophageal cancer	3.76e-05	0.000274	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PSME1—esophageal cancer	3.75e-05	0.000273	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PSME2—esophageal cancer	3.75e-05	0.000273	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTT1—esophageal cancer	3.74e-05	0.000272	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP2A6—esophageal cancer	3.69e-05	0.000269	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GNG7—esophageal cancer	3.69e-05	0.000268	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ENO1—esophageal cancer	3.65e-05	0.000266	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS1—esophageal cancer	3.65e-05	0.000266	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ABCB1—esophageal cancer	3.61e-05	0.000263	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ABCB1—esophageal cancer	3.61e-05	0.000263	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PSME2—esophageal cancer	3.6e-05	0.000262	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PSME1—esophageal cancer	3.6e-05	0.000262	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ENO1—esophageal cancer	3.5e-05	0.000255	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS1—esophageal cancer	3.5e-05	0.000255	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—HMOX1—esophageal cancer	3.48e-05	0.000254	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALDH2—esophageal cancer	3.45e-05	0.000251	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PSME2—esophageal cancer	3.45e-05	0.000251	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PSME1—esophageal cancer	3.45e-05	0.000251	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	3.4e-05	0.000248	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ABCB1—esophageal cancer	3.34e-05	0.000244	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTT1—esophageal cancer	3.28e-05	0.000239	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP2A6—esophageal cancer	3.25e-05	0.000236	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP1B1—esophageal cancer	3.24e-05	0.000236	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	3.23e-05	0.000235	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	3.2e-05	0.000233	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP1B1—esophageal cancer	3.11e-05	0.000226	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ENO1—esophageal cancer	3.08e-05	0.000224	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS1—esophageal cancer	3.08e-05	0.000224	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP19A1—esophageal cancer	3.05e-05	0.000222	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PSME2—esophageal cancer	3.03e-05	0.000221	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PSME1—esophageal cancer	3.03e-05	0.000221	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	3.03e-05	0.000221	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP1B1—esophageal cancer	2.98e-05	0.000217	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP19A1—esophageal cancer	2.92e-05	0.000213	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—TP53—esophageal cancer	2.91e-05	0.000212	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP19A1—esophageal cancer	2.8e-05	0.000204	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HMOX1—esophageal cancer	2.78e-05	0.000202	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ABCB1—esophageal cancer	2.67e-05	0.000194	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HMOX1—esophageal cancer	2.66e-05	0.000194	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CREBBP—esophageal cancer	2.65e-05	0.000193	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1B1—esophageal cancer	2.62e-05	0.000191	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CREBBP—esophageal cancer	2.58e-05	0.000188	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CREBBP—esophageal cancer	2.58e-05	0.000188	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	2.58e-05	0.000188	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ABCB1—esophageal cancer	2.56e-05	0.000186	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HMOX1—esophageal cancer	2.55e-05	0.000186	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	2.54e-05	0.000185	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP19A1—esophageal cancer	2.46e-05	0.000179	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ABCB1—esophageal cancer	2.45e-05	0.000179	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	2.42e-05	0.000176	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CREBBP—esophageal cancer	2.41e-05	0.000176	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CREBBP—esophageal cancer	2.41e-05	0.000176	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	2.39e-05	0.000174	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—NOS3—esophageal cancer	2.37e-05	0.000173	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NOS3—esophageal cancer	2.31e-05	0.000168	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NOS3—esophageal cancer	2.31e-05	0.000168	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HMOX1—esophageal cancer	2.25e-05	0.000163	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CREBBP—esophageal cancer	2.24e-05	0.000163	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS2—esophageal cancer	2.17e-05	0.000158	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NOS3—esophageal cancer	2.16e-05	0.000157	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NOS3—esophageal cancer	2.16e-05	0.000157	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ABCB1—esophageal cancer	2.16e-05	0.000157	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS2—esophageal cancer	2.12e-05	0.000154	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS2—esophageal cancer	2.12e-05	0.000154	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NOS3—esophageal cancer	2e-05	0.000146	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS2—esophageal cancer	1.98e-05	0.000144	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS2—esophageal cancer	1.98e-05	0.000144	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS2—esophageal cancer	1.83e-05	0.000133	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—EP300—esophageal cancer	1.81e-05	0.000132	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CREBBP—esophageal cancer	1.78e-05	0.00013	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—EP300—esophageal cancer	1.76e-05	0.000128	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—EP300—esophageal cancer	1.76e-05	0.000128	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CREBBP—esophageal cancer	1.71e-05	0.000124	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—EP300—esophageal cancer	1.64e-05	0.00012	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—EP300—esophageal cancer	1.64e-05	0.00012	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CREBBP—esophageal cancer	1.64e-05	0.000119	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NOS3—esophageal cancer	1.6e-05	0.000116	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NOS3—esophageal cancer	1.53e-05	0.000111	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—EP300—esophageal cancer	1.52e-05	0.000111	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NOS3—esophageal cancer	1.47e-05	0.000107	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS2—esophageal cancer	1.46e-05	0.000106	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CREBBP—esophageal cancer	1.44e-05	0.000105	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS2—esophageal cancer	1.4e-05	0.000102	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS2—esophageal cancer	1.34e-05	9.77e-05	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CA—esophageal cancer	1.34e-05	9.73e-05	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CA—esophageal cancer	1.3e-05	9.48e-05	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CA—esophageal cancer	1.3e-05	9.48e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC52A3—esophageal cancer	1.3e-05	9.48e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—BLVRB—esophageal cancer	1.3e-05	9.48e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NOS3—esophageal cancer	1.29e-05	9.39e-05	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CA—esophageal cancer	1.22e-05	8.85e-05	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CA—esophageal cancer	1.22e-05	8.85e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—EP300—esophageal cancer	1.21e-05	8.84e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS2—esophageal cancer	1.18e-05	8.59e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—EP300—esophageal cancer	1.16e-05	8.48e-05	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CA—esophageal cancer	1.13e-05	8.2e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—EP300—esophageal cancer	1.12e-05	8.13e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CA1—esophageal cancer	1.11e-05	8.06e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.11e-05	8.06e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CA2—esophageal cancer	1.01e-05	7.37e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—EP300—esophageal cancer	9.81e-06	7.14e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADH7—esophageal cancer	9.41e-06	6.85e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.41e-06	6.85e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CA—esophageal cancer	8.98e-06	6.54e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CA—esophageal cancer	8.61e-06	6.27e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CA—esophageal cancer	8.26e-06	6.01e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.25e-06	6.01e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TYMP—esophageal cancer	7.89e-06	5.74e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.67e-06	5.59e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.48e-06	5.44e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CA—esophageal cancer	7.26e-06	5.28e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TPI1—esophageal cancer	7.13e-06	5.19e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.13e-06	5.19e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.84e-06	4.98e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.58e-06	4.79e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.52e-06	4.75e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GNG7—esophageal cancer	6.2e-06	4.52e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.81e-06	4.23e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.53e-06	4.03e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.47e-06	3.98e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.18e-06	3.77e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ENO1—esophageal cancer	5.18e-06	3.77e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PSME2—esophageal cancer	5.11e-06	3.72e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PSME1—esophageal cancer	5.11e-06	3.72e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.41e-06	3.21e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.14e-06	3.02e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.78e-06	2.75e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.63e-06	2.64e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.42e-06	1.77e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NOS3—esophageal cancer	2.17e-06	1.58e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.99e-06	1.45e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—EP300—esophageal cancer	1.65e-06	1.2e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.22e-06	8.9e-06	CbGpPWpGaD
